170 likes | 318 Views
Disclosures. Consultant: BMS, Guerbet, Sanofi-Aventis, Schering-Plough, The Medicines Co.Grant Support: Guerbet, The Medicines Co.Lecture honoraria: Guerbet, The Medicines Co.. Manoukian SV et al. TCT 2007.. Background and Methods: Study Design and Definitions. The ACUITY Trial randomized 13,819
E N D
1. Major Bleeding is Associated with Increased One-Year Mortality and Ischemic Events in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervetnion:The ACUITY Trial Steven V. Manoukian, Frederick Feit, Michele D. Voeltz,
George D. Dangas, Ramin Ebrahimi, Martial Hamon,
Derek P. Chew, Walter Desmet, Steven R. Steinhubl,
A. Michael Lincoff, Spencer B. King III, E. Magnus Ohman, Harvey D. White, Roxana Mehran, Gregg W. Stone,
on behalf of the ACUITY Investigators
2. Disclosures Consultant: BMS, Guerbet, Sanofi-Aventis, Schering-Plough, The Medicines Co. Grant Support: Guerbet, The Medicines Co. Lecture honoraria: Guerbet, The Medicines Co.